Physician profile
John D Witter
NPI 1578208799
$1,062.41
in general payments reported to CMS, 2019-2025
12 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $257.32 | 2025 | Puraply Wound Matrix, Via Matrix, Simplimax |
| Solventum Corporation | $156.92 | 2025 | Activ.A.C., V.A.C.Ulta, Prevena |
| Urgo Medical North America, LLC | $140.37 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kerecis Limited | $137.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $131.41 | 2025 | Novosorb Btm |
| Orthofix Medical, INC. | $91.21 | 2025 | Accelstim, Physio-Stim |
| Smith+Nephew, INC. | $33.40 | 2025 | Collagenase Santyl, Renasys Go V2 Home |
| Stryker Corporation | $30.06 | 2025 | 7 X 23mm Citrelock Implant |
| Ani Pharmaceuticals, INC. | $23.63 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $21.79 | 2025 | Krystexxa |
| Djo, LLC | $20.98 | 2025 | Cmf |
| Treace Medical Concepts, INC. | $17.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Witter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.